Sandra Goble

6.8k total citations
66 papers, 1.9k citations indexed

About

Sandra Goble is a scholar working on Oncology, Reproductive Medicine and Emergency Medicine. According to data from OpenAlex, Sandra Goble has authored 66 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Oncology, 21 papers in Reproductive Medicine and 15 papers in Emergency Medicine. Recurrent topics in Sandra Goble's work include PARP inhibition in cancer therapy (39 papers), Ovarian cancer diagnosis and treatment (21 papers) and Trauma and Emergency Care Studies (15 papers). Sandra Goble is often cited by papers focused on PARP inhibition in cancer therapy (39 papers), Ovarian cancer diagnosis and treatment (21 papers) and Trauma and Emergency Care Studies (15 papers). Sandra Goble collaborates with scholars based in United States, United Kingdom and Canada. Sandra Goble's co-authors include Avery B. Nathens, Marc A. Bjurlin, Mark R. Hemmila, Shahid Shafi, John Fildes, Melanie L. Neal, Richard J Fantus, David E. Clark, Heidi Giordano and Michael D. Pasquale and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Annals of Surgery.

In The Last Decade

Sandra Goble

65 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sandra Goble United States	22	744	693	633	324	287	66	1.9k
Camran Nezhat United States	42	312 0.4×	151 0.2×	1.5k 2.3×	110 0.3×	3.6k 12.4×	148	5.0k
Valérie Bridoux France	26	149 0.2×	538 0.8×	1.3k 2.0×	27 0.1×	757 2.6×	107	2.0k
Bassam Haddad France	28	49 0.1×	111 0.2×	501 0.8×	219 0.7×	214 0.7×	125	2.6k
Codruța Chiuzan United States	22	103 0.1×	973 1.4×	532 0.8×	592 1.8×	20 0.1×	79	2.3k
Ralph H.M. Hermans Netherlands	16	368 0.5×	430 0.6×	1.4k 2.2×	97 0.3×	1.0k 3.6×	34	2.4k
Sunil V. Patel Canada	23	139 0.2×	611 0.9×	775 1.2×	136 0.4×	11 0.0×	87	1.7k
Christian J. Streck United States	23	461 0.6×	120 0.2×	606 1.0×	237 0.7×	7 0.0×	60	1.4k
William H. Parker United States	24	66 0.1×	238 0.3×	662 1.0×	49 0.2×	2.6k 9.2×	68	4.1k
Jean‐Luc Faucheron France	26	91 0.1×	903 1.3×	2.0k 3.2×	26 0.1×	40 0.1×	122	2.4k
Richard Barron United States	22	82 0.1×	736 1.1×	184 0.3×	93 0.3×	13 0.0×	55	1.3k

Countries citing papers authored by Sandra Goble

Since Specialization

Citations

This map shows the geographic impact of Sandra Goble's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Goble with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Goble more than expected).

Fields of papers citing papers by Sandra Goble

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra Goble. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Goble. The network helps show where Sandra Goble may publish in the future.

Co-authorship network of co-authors of Sandra Goble

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra Goble. A scholar is included among the top collaborators of Sandra Goble based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra Goble. Sandra Goble is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Coleman, Robert L., Amit M. Oza, Domenica Lorusso, et al.. (2022). 2022-RA-249-ESGO Overall survival results from ariel3: a phase 3 randomised, double-blind study of rucaparib vs placebo following response to platinum-based chemotherapy for recurrent ovarian carcinoma. International Journal of Gynecological Cancer. 32. A226–A226. 16 indexed citations

Lee, Chee Khoon, Michael Friedländer, Jonathan A. Ledermann, et al.. (2021). Molecular and clinical predictors of improvement in progression‐free survival with maintenance PARP inhibitor therapy in women with platinum‐sensitive, recurrent ovarian cancer: A meta‐analysis. Cancer. 127(14). 2432–2441. 19 indexed citations

Dean, Andrew, Amit M. Oza, Domenica Lorusso, et al.. (2020). 821P Timing of adverse events during maintenance treatment with rucaparib for recurrent ovarian cancer in the phase III ARIEL3 study. Annals of Oncology. 31. S620–S621. 1 indexed citations

Shroff, Rachna T., Andrew Hendifar, Robert R. McWilliams, et al.. (2018). Rucaparib Monotherapy in Patients With Pancreatic Cancer and a Known Deleterious BRCA Mutation. JCO Precision Oncology. 2018(2). 1–15. 137 indexed citations

Kristeleit, Rebecca, Geoffrey I. Shapiro, Howard A. Burris, et al.. (2017). A Phase I–II Study of the Oral PARP Inhibitor Rucaparib in Patients with Germline BRCA1/2 -Mutated Ovarian Carcinoma or Other Solid Tumors. Clinical Cancer Research. 23(15). 4095–4106. 186 indexed citations

Kristeleit, Rebecca, Domenica Lorusso, Ana Oaknin, et al.. (2017). ARIEL4: An international, randomised phase 3 study of the PARP inhibitor rucaparib vs chemotherapy for the treatment of BRCA-mutated, relapsed, high-grade ovarian cancer. Annals of Oncology. 28. v352–v352. 1 indexed citations

Ledermann, Jonathan A., Amit M. Oza, Domenica Lorusso, et al.. (2017). ARIEL3: A phase 3, randomised, double-blind study of rucaparib vs placebo following response to platinum-based chemotherapy for recurrent ovarian carcinoma (OC). Annals of Oncology. 28. v625–v625. 5 indexed citations

Shapira‐Frommer, Ronnie, Ana Oaknin, Judith Balmañà, et al.. (2016). Clinical activity of the poly(ADP-ribose) polymerase (PARP) inhibitor rucaparib in patients (pts) with high-grade ovarian carcinoma (HGOC) and a BRCA mutation (BRCAmut): Analysis of pooled data from Study 10 (parts 1, 2a, and 3) and ARIEL2 (parts 1 and 2). Annals of Oncology. 27. vi296–vi296. 21 indexed citations

Goble, Sandra, et al.. (2014). QoL in Patients with nocturia: Does the study design impact the outcome?. Neurourology and Urodynamics. 2 indexed citations

10.

Juul, Kristian Vinter, Charlotte Van Herzeele, Pauline De Bruyne, et al.. (2013). Desmopressin melt improves response and compliance compared with tablet in treatment of primary monosymptomatic nocturnal enuresis. European Journal of Pediatrics. 172(9). 1235–1242. 30 indexed citations

11.

Bjurlin, Marc A., et al.. (2011). Is Routine Postoperative Chest Radiography Needed After Percutaneous Nephrolithotomy?. Urology. 79(4). 791–795. 12 indexed citations

12.

Bjurlin, Marc A., Eric I. Jeng, Sandra Goble, James C. Doherty, & Gary J. Merlotti. (2011). Comparison of Nonoperative Management With Renorrhaphy and Nephrectomy in Penetrating Renal Injuries. The Journal of Trauma: Injury, Infection, and Critical Care. 71(3). 554–558. 26 indexed citations

13.

Schlüter, Philip J., Avery B. Nathens, Melanie L. Neal, et al.. (2010). Trauma and Injury Severity Score (TRISS) Coefficients 2009 Revision. The Journal of Trauma: Injury, Infection, and Critical Care. 68(4). 761–770. 97 indexed citations

14.

Hemmila, Mark R., Avery B. Nathens, Shahid Shafi, et al.. (2010). The Trauma Quality Improvement Program: Pilot Study and Initial Demonstration of Feasibility. The Journal of Trauma: Injury, Infection, and Critical Care. 68(2). 253–262. 165 indexed citations

15.

Shafi, Shahid, Sunni A. Barnes, David Nicewander, et al.. (2010). Health Care Reform at Trauma Centers—Mortality, Complications, and Length of Stay. The Journal of Trauma: Injury, Infection, and Critical Care. 69(6). 1367–1371. 36 indexed citations

16.

Shafi, Shahid, Jennifer Parks, Chul Ahn, et al.. (2010). Centers for Medicare and Medicaid Services Quality Indicators Do Not Correlate With Risk-Adjusted Mortality at Trauma Centers. The Journal of Trauma: Injury, Infection, and Critical Care. 68(4). 771–777. 20 indexed citations

17.

Gómez, David, Barbara Haas, Mark R. Hemmila, et al.. (2010). Hips Can Lie: Impact of Excluding Isolated Hip Fractures on External Benchmarking of Trauma Center Performance. The Journal of Trauma: Injury, Infection, and Critical Care. 69(5). 1037–1041. 37 indexed citations

18.

Ingraham, Angela M., Wei Xiong, Mark R. Hemmila, et al.. (2010). The Attributable Mortality and Length of Stay of Trauma-Related Complications. Annals of Surgery. 252(2). 358–362. 94 indexed citations

19.

Goble, Sandra, Melanie Neal, David E. Clark, et al.. (2009). Creating a Nationally Representative Sample of Patients From Trauma Centers. The Journal of Trauma: Injury, Infection, and Critical Care. 67(3). 637–644. 16 indexed citations

20.

Shafi, Shahid, Avery B. Nathens, Gill H. Cryer, et al.. (2009). The Trauma Quality Improvement Program of the American College of Surgeons Committee on Trauma. Journal of the American College of Surgeons. 209(4). 521–530e1. 163 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact